Nomura Yukihiro, Murata Hiroyuki, Sasai Hiroaki, Kimura Akihiko, Kurosawa Takao, Sasaki Takahiro, Murai Tsuyoshi
Drug Metabolism and Pharmacokinetics Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc.
Department of Pediatrics and Child Health, Kurume University School of Medicine.
Biol Pharm Bull. 2018;41(4):597-603. doi: 10.1248/bpb.b17-00986.
Unusual bile acids (1β-hydroxylated bile acids), particularly 1β-hydroxyl-cholic acid (CA-1β-ol) and 1β-hydroxyl-chenodeoxycholic acid (CDCA-1β-ol), have been detected in the urine of infants. These acids are conjugated with amino acids, such as taurine, and are then excreted mainly via the urine. CA-1β-ol and CDCA-1β-ol are the predominant bile acids during infancy and are present in relatively large amounts in the urine. However, the biosynthetic pathway of 1β-hydroxylated bile acids in infants remains unclear. To investigate the biosynthetic pathway of 1β-hydroxylated bile acids during infancy, we performed a metabolic reaction using infant hepatocytes at 3 months after delivery. Glyco- and tauro-CA-1β-ol were identified by LC/tandem mass spectrometry (MS/MS) analysis of the extracted culture medium incubated with cholic acids (CAs). Further, we identified that ketoconazole suppressed CA 1β-hydroxylation and that the CYP3A subfamily was the primary group of enzymes responsible for CA-1β-ol formation. The present study provides new information about the biosynthetic pathway of 1β-hydroxylated bile acids during infancy.
在婴儿尿液中检测到了异常胆汁酸(1β-羟基化胆汁酸),尤其是1β-羟基胆酸(CA-1β-ol)和1β-羟基鹅去氧胆酸(CDCA-1β-ol)。这些酸与氨基酸(如牛磺酸)结合,然后主要通过尿液排出。CA-1β-ol和CDCA-1β-ol是婴儿期的主要胆汁酸,在尿液中含量相对较高。然而,婴儿期1β-羟基化胆汁酸的生物合成途径仍不清楚。为了研究婴儿期1β-羟基化胆汁酸的生物合成途径,我们在婴儿出生后3个月使用婴儿肝细胞进行了代谢反应。通过对与胆酸(CAs)孵育的提取培养基进行液相色谱/串联质谱(MS/MS)分析,鉴定出了甘氨和牛磺CA-1β-ol。此外,我们还确定酮康唑可抑制CA 1β-羟基化,且CYP3A亚家族是负责CA-1β-ol形成的主要酶类。本研究提供了有关婴儿期1β-羟基化胆汁酸生物合成途径的新信息。